CEPHALON INC SEC Filings

Filed On	Filing
31 Mar 2017	AMENDMENT NO.2 TO SCHEDULE 13G
10 Mar 2017	AMENDMENT NO.1 TO SCHEDULE 13G
27 Mar 2015	Form 3: Cephalon Inc, 10% owner and 1 other · Ignyta, Inc. Holds 3,000,000 shares of Common Stock
27 Mar 2015	SC 13G
10 Feb 2012	SC 13G/A
26 Jan 2012	SC 13G/A
21 Dec 2011	POSASR
21 Dec 2011	S-8 POS
21 Dec 2011	S-8 POS
21 Dec 2011	S-8 POS
21 Dec 2011	S-8 POS
21 Dec 2011	S-8 POS
21 Dec 2011	S-8 POS
14 Nov 2011	SC 13D
19 Oct 2011	15-12G
17 Oct 2011	Form 4: Vaught Jeffry L, Exec VP, Chief Scientific Off Returned 98,620 shares to the issuer · Disposed of 10,799 Incentive Stock Option (Disposition to Issuer) · Disposed of 322,331 Non-Qualified Stock Option (Disposition to Issuer)
17 Oct 2011	Form 4: Savini Carl A, Exec VP, Chief Admin Off Returned 87,032 shares to the issuer · Disposed of 14,953 Incentive Stock Option (Disposition to Issuer) · Disposed of 335,122 Non-Qualified Stock Option (Disposition to Issuer)
17 Oct 2011	Form 4: Winger Dennis L, Director Disposed of 105,000 Non-Qualified Stock Option (Disposition to Issuer)
17 Oct 2011	Form 4: Russell Lesley, Exec VP, Chief Medical Off Returned 101,595 shares to the issuer · Disposed of 203,239 Non-Qualified Stock Option (Disposition to Issuer) · Disposed of 56,887 Non-Qualifed Stock Option (Disposition to Issuer) · 1 more
17 Oct 2011	Form 4: Wilensky Gail R, Director Disposed of 105,000 Non-Qualified Stock Option (Disposition to Issuer)

Comments